Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 4,176–4,200 of 7,816 matching trials · page 168 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Wayfinding Intervention in High-Fidelity Long-Term Memory NCT04253587 LabyrinthVR; Placebo Games; Coherence; Tablet Runs in: United States · 1 site |
NA other |
COMPLETED | 50 | University of California, San Francisco OTHER |
2023-02-27 |
|
Exer-game Balance Training on Dementia NCT05158595 Exergaming low intensity group; Exergaming moderate intensity group... Runs in: Pakistan · 1 site |
NA other |
COMPLETED | 40 | Riphah International University OTHER |
2023-02-24 |
|
Assistive Technology and Reduced Caregiver Burden NCT05352529 The MapHabit system; Dementia educational videos Runs in: United States · 1 site |
NA other |
COMPLETED | 16 | MapHabit, Inc. INDUSTRY |
2023-02-24 |
|
Tango for Older People With Dementia NCT05744011 Tango intervention; Adapted Physical Activity Runs in: France · 2 sites |
NA other |
UNKNOWN | 124 | University of Burgundy OTHER |
2023-02-24 |
|
GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease NCT03823404 COR388 capsule; Placebo capsule Runs in: France; Netherlands; Poland; Spain; United Kingdom; United States · 93 sites |
PHASE2|PHASE3 other |
COMPLETED | 643 | Cortexyme Inc. INDUSTRY |
2023-02-23 |
|
Clinical Trial to Explore the the Amyloid Beta Draining Effect of Thiethylperazine (TEP) in Subjects With Newly Diagnosed Early-to-mild Dementia Due to Alzheimer's Disease (AD) in Comparison to Healthy Volunteers NCT03417986 TEP Runs in: Germany · 2 sites |
PHASE2 other |
COMPLETED | 20 | Immungenetics AG INDUSTRY |
2023-02-22 |
|
Impact of Grape Consumption on Brain Metabolism and Neuropsychological Performance Over 1 Year NCT03361410 Grape Powder; Placebo Powder Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 32 | University of California, Los Angeles OTHER |
2023-02-21 |
|
Efficacy and Safety of Yangxue Qingnao Pills in the Treatment of Mild to Moderate Alzheimer's Disease NCT04780399 Yangxue Qingnao pills; Yangxue Qingnao pills; Placebo Runs in: China · 1 site |
PHASE2 other |
UNKNOWN | 216 | Dongzhimen Hospital, Beijing OTHER |
2023-02-21 |
|
Engagement 2.0 Forms of Consent for Data (re-)Use NCT05229978 Showing an existing Dynamic Consent (computer interface) as prompt Runs in: Belgium · 1 site |
NA other |
COMPLETED | 23 | Universitair Ziekenhuis Brussel OTHER |
2023-02-21 |
|
Randomised Controlled Trial for the selfBACK Project NCT03798288 selfBACK; Usual care Runs in: Denmark; Norway · 2 sites |
NA other |
COMPLETED | 461 | University of Southern Denmark OTHER |
2023-02-17 |
|
Phase1a, Dose-escalation Study of NNI-362 in Healthy Aged Volunteers NCT04074837 NNI-362; Placebo Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 56 | Neuronascent, Inc. INDUSTRY |
2023-02-17 |
|
Effects of Functional Training by High Intensity Intervals in Older Adults With Mild Cognitive Impairment. NCT04638322 HIFT Group Runs in: Colombia · 1 site |
NA other |
COMPLETED | 52 | University of Jaén OTHER |
2023-02-17 |
|
Music Therapy for Persons With Dementia NCT03643003 Music therapy; Non-Music Verbal Interaction (Placebo) Runs in: United States · 1 site |
NA other |
COMPLETED | 32 | University of Iowa OTHER |
2023-02-16 |
|
SHARE(D) Stage II: Alzheimer's Risk Disclosure Protocol Piloting NCT04309500 Personalized DAT Risk Disclosure Protocol Runs in: United States · 1 site |
NA other |
COMPLETED | 20 | University of Michigan OTHER |
2023-02-16 |
|
Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease NCT04436081 THC-free CBD Oil; Placebo Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 40 | Eastern Virginia Medical School OTHER |
2023-02-16 |
|
Preventing Cognitive Decline: The CITA GO-ON Multi-domain Intervention Study NCT04840030 Multimodal intervention (MM-int) Runs in: Spain · 1 site |
NA other |
ENROLLING_BY_INVITATION | 1,094 | Fundacion CITA-alzheimer OTHER |
2023-02-16 |
|
Safety, Tolerability and Pharmacokinetics of CMS121, a Drug Candidate for Alzheimer's Disease, in Healthy Subjects NCT05318040 CMS121; Placebo Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 99 | Virogenics, Inc. INDUSTRY |
2023-02-16 |
|
Immersive Virtual Reality for Dual-task Training in Older Adults With Mild Cognitive Impairment: A Randomized Controlled Trial NCT05730790 Cognitive-motor dual task training (DTT); Cognitive single task tra... Runs in: Singapore · 1 site |
NA other |
UNKNOWN | 54 | Tan Tock Seng Hospital OTHER |
2023-02-16 |
|
Exercise in Adults With Mild Memory Problems NCT02814526 Aerobic exercise; Stretching/balance/range of motion exercise Runs in: United States · 14 sites |
NA other |
COMPLETED | 296 | Alzheimer's Disease Cooperative Study (ADCS) OTHER |
2023-02-15 |
|
Coenzyme Q10 Phase III Trial in Gulf War Illness NCT02865460 Ubiquinol; Placebo Runs in: United States · 4 sites |
PHASE3 other |
COMPLETED | 100 | VA Office of Research and Development OTHER_GOV |
2023-02-15 |
|
Efavirenz for Patients With Alzheimer's Disease NCT03706885 Sustiva Pill Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 5 | Case Western Reserve University OTHER |
2023-02-15 |
|
Microbial Determinants of Dementia Risk in Type 2 Diabetics of Mexican Descent NCT04602650 Runs in: United States · 1 site |
NA other |
COMPLETED | 12 | The University of Texas Medical Branch, Galveston OTHER |
2023-02-15 |
|
Effect of Treatment With EGb 761(r) on Blood Markers of Inflammation and Oxidative Stress in Patients With MCI NCT05594355 TEBOFORTAN Runs in: Spain · 1 site |
PHASE4 other |
UNKNOWN | 100 | Fundació ACE Institut Català de Neurociències Aplicades OTHER |
2023-02-15 |
|
Validity and Reliability of the GPCOG -TR NCT05704452 Runs in: Turkey (Türkiye) · 1 site |
NA other |
UNKNOWN | 230 | Yeditepe University OTHER |
2023-02-15 |
|
Transcranial Magnetic Stimulation in Patients With Mild Cognitive Impairment - RCT Trial NCT05730296 TMS; TMS; TMS Runs in: Poland · 1 site |
NA other |
UNKNOWN | 60 | Wroclaw Medical University OTHER |
2023-02-15 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial